CD276 and Miyoshi myopathy: SupT-1 cells served as negative control target cells (B7-H3neg), while NCI-H929 (B7-H3low), L-363 (B7-H3medium), and KMS-12-PE (B7-H3high) cells were selected as MM target cells expressing varying levels of B7-H3.